Browse by Series:

FDA Acts Against Companies Selling Illegal Cancer Treatments and Clearance on Scalp Cooling System

Roy Herbst, MD
Published: Friday, Apr 28, 2017



Roy Herbst, MD, of Yale Cancer Center, reports on the FDA acting against companies illegally selling cancer treatments, an FDA clearance on a second scalp cooling system, promising phase III trials in breast cancer, and early findings with immunotherapy in liver cancer.
SELECTED
LANGUAGE
Slider Left
Slider Right


Roy Herbst, MD, of Yale Cancer Center, reports on the FDA acting against companies illegally selling cancer treatments, an FDA clearance on a second scalp cooling system, promising phase III trials in breast cancer, and early findings with immunotherapy in liver cancer.
View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: Oncology Best Practice™ Decision Points in Advanced NSCLC: Assessing Treatment Options Beyond Disease ProgressionNov 30, 20181.0
Community Practice Connections™: Precision Medicine for Community Oncologists: Assessing the Role of Tumor-Testing Technologies in Cancer CareNov 30, 20181.0
Publication Bottom Border
Border Publication
x